Page last updated: 2024-08-23

zidovudine and Anemia, Macrocytic

zidovudine has been researched along with Anemia, Macrocytic in 10 studies

Research

Studies (10)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (10.00)	18.7374
1990's	3 (30.00)	18.2507
2000's	5 (50.00)	29.6817
2010's	1 (10.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Han, K; Jang, W; Kim, AH; Kim, Y; Oh, EJ; Park, YJ	1
Empey, K; Pomeroy, C; Romanelli, F	1
Clark, PL; Hinthorn, D; Myers, SA; Torrente, S	1
Heitzmann, F; Keusch, G; Kis, L; Möddel, M	1
Bullis, J; Cronkite, E; Honikel, L	1
Bullis, JE; Cronkite, EP; Hirabayashi, Y; Inoue, T; Mitsui, H; Umemura, T	1
Dousman, L; Freund, YR; MacGregor, JT; Mohagheghpour, N	1
Battegay, M; Tichelli, A; Wolf, K	1
Borderi, M; Chiodo, F; Costigliola, P; Guariento, A; Manfredi, R; Ricchi, E; Silvestri, MG	1
Oksenhendler, E	1

Reviews

1 review(s) available for zidovudine and Anemia, Macrocytic

Article	Year
Azidothymidine. Nouvelle revue francaise d'hematologie, 1989, Volume: 31, Issue:2 Topics: Acquired Immunodeficiency Syndrome; Anemia, Macrocytic; Clinical Trials as Topic; Drug Interactions; HIV; Humans; Neutropenia; Random Allocation; Zidovudine	1989

Trials

1 trial(s) available for zidovudine and Anemia, Macrocytic

Article	Year
Azidothymidine. Nouvelle revue francaise d'hematologie, 1989, Volume: 31, Issue:2 Topics: Acquired Immunodeficiency Syndrome; Anemia, Macrocytic; Clinical Trials as Topic; Drug Interactions; HIV; Humans; Neutropenia; Random Allocation; Zidovudine	1989

Other Studies

9 other study(ies) available for zidovudine and Anemia, Macrocytic

Article	Year
Mean corpuscular volume (MCV) values reflect therapeutic effectiveness in zidovudine-receiving HIV patients. Journal of clinical laboratory analysis, 2013, Volume: 27, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Anemia, Macrocytic; Anti-HIV Agents; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cholesterol, HDL; Cholesterol, LDL; Erythrocyte Indices; Female; HIV Infections; Humans; Male; Middle Aged; Reverse Transcriptase Inhibitors; RNA, Viral; Sensitivity and Specificity; Treatment Outcome; Viral Load; Young Adult; Zidovudine	2013
Macrocytosis as an indicator of medication (zidovudine) adherence in patients with HIV infection. AIDS patient care and STDs, 2002, Volume: 16, Issue:9 Topics: Adult; Anemia, Macrocytic; Anti-HIV Agents; Case-Control Studies; Chi-Square Distribution; Erythrocyte Indices; Female; HIV Infections; Humans; Incidence; Male; Patient Compliance; Retrospective Studies; Stavudine; Treatment Outcome; Zidovudine	2002
Life-threatening maternal and fetal macrocytic anemia from antiretroviral therapy. Obstetrics and gynecology, 2005, Volume: 106, Issue:5 Pt 2 Topics: Adult; Anemia, Macrocytic; Anti-HIV Agents; Cesarean Section; Drug Therapy, Combination; Female; Fetal Diseases; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Pregnancy; Pregnancy Complications, Hematologic; Pregnancy Complications, Infectious; Pregnancy Outcome; Viral Load; Zidovudine	2005
[Severe anemia in the framework of zidovudine treatment in HIV disease]. Praxis, 2006, Jan-25, Volume: 95, Issue:4 Topics: Acute Disease; Adult; Anemia, Macrocytic; Anti-HIV Agents; Diagnosis, Differential; Female; Follow-Up Studies; HIV Infections; Humans; Reverse Transcriptase Inhibitors; Time Factors; Zidovudine	2006
Partial amelioration of AZT-induced macrocytic anemia in the mouse by folic acid. Stem cells (Dayton, Ohio), 1993, Volume: 11, Issue:5 Topics: Anemia, Macrocytic; Animals; Folic Acid; Male; Mice; Mice, Inbred CBA; Zidovudine	1993
Lifetime treatment of mice with azidothymidine (AZT) produces myelodysplasia. Leukemia, 1997, Volume: 11 Suppl 3 Topics: Acquired Immunodeficiency Syndrome; Anemia, Macrocytic; Animals; Anti-HIV Agents; Bone Marrow; Colony-Forming Units Assay; Erythrocyte Count; Hematopoiesis; Hematopoietic Stem Cells; Humans; Hyperplasia; Male; Mice; Mice, Inbred CBA; Myelodysplastic Syndromes; Thrombocytopenia; Time Factors; Zidovudine	1997
Oral treatment with trimethoprim-sulfamethoxazole and zidovudine suppresses murine accessory cell-dependent immune responses. Toxicological sciences : an official journal of the Society of Toxicology, 2000, Volume: 55, Issue:2 Topics: Administration, Oral; Anemia, Macrocytic; Animals; Anti-HIV Agents; Anti-Infective Agents; Antigen-Presenting Cells; Concanavalin A; Drug Combinations; Female; Hematopoiesis; Immunity, Cellular; Immunosuppression Therapy; Lipopolysaccharides; Lymphocyte Activation; Lymphocyte Count; Mice; Mice, Inbred BALB C; Pancytopenia; Spleen; T-Lymphocytes; Trimethoprim, Sulfamethoxazole Drug Combination; Tumor Cells, Cultured; Zidovudine	2000
[Anemia, neutropenia and thrombocytopenia: hematological findings and HIV]. Praxis, 2001, Oct-11, Volume: 90, Issue:41 Topics: Adult; Anemia, Macrocytic; Anti-HIV Agents; Biopsy; Bone Marrow; Diagnosis, Differential; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; HIV Infections; Humans; Male; Neutropenia; Thrombocytopenia; Zidovudine	2001
[Monitoring of several hematological parameters of the erythroid series in patients with HIV infection treated with zidovudine]. Recenti progressi in medicina, 1992, Volume: 83, Issue:6 Topics: Adult; Anemia, Macrocytic; Bone Marrow; Drug Monitoring; Female; HIV Infections; Humans; Male; Reticulocytes; Time Factors; Zidovudine	1992